Showing results (31-40 of 85) with videos related to
Sort By:
Pageof 9
Acta Neuropsychiatrica|November 6, 2018
Associations between C-reactive protein levels and cognition during the first 6 months after acute psychosisFarivar Fathian, Else-Marie Løberg, Rolf Gjestad, et al.Frontiers in Psychiatry|February 20, 2014
A critical review of pro-cognitive drug targets in psychosis: convergence on myelination and inflammationRune A Kroken, Else-Marie Løberg, Tore Drønen, et al.World Journal of Psychiatry|January 13, 2017
Influence of different second generation antipsychotics on the QTc interval: A pragmatic studyRoy E Olsen, Rune A Kroken, Sigmund Bjørhovde, et al.Frontiers in Psychiatry|November 2, 2012
An fMRI Study of Neuronal Activation in Schizophrenia Patients with and without Previous Cannabis UseElse-Marie Løberg, Merethe Nygård, Jan Øystein Berle, et al.Nordic Journal of Psychiatry|January 12, 2016
Patient satisfaction after acute admission for psychosisBeate Bø, Øyvind H Ottesen, Rolf Gjestad, et al.BMC Psychiatry|March 15, 2016
The serum level of C-reactive protein (CRP) is associated with cognitive performance in acute phase psychosisErik Johnsen, Farivar Fathian, Rune A Kroken, et al.BMC Psychiatry|March 16, 2022
Prevalence and correlates of suicide attempts in high-risk populations: a cross-sectional study among patients receiving opioid agonist therapy in NorwayJørn Henrik Vold, Else-Marie Løberg, Christer F Aas, et al.Schizophrenia Research|May 14, 2013
Failure of attention focus and cognitive control in schizophrenia patients with auditory verbal hallucinations: evidence from dichotic listeningKenneth Hugdahl, Merethe Nygård, Liv E Falkenberg, et al.Frontiers in Psychiatry|April 18, 2020
Dynamic Functional Connectivity Patterns in Schizophrenia and the Relationship With HallucinationsSarah Weber, Erik Johnsen, Rune A Kroken, et al.BMC Psychiatry|June 29, 2023
Attention-deficit/hyperactivity disorder (ADHD) symptoms and their relation to diagnosed ADHD, sociodemographic characteristics, and substance use among patients receiving opioid agonist therapy: a Norwegian cohort studyJørn Henrik Vold, Anne Halmøy, Fatemeh Chalabianloo, et al.Pageof 9